Maximizing Weight Loss vs. Protecting the Heart: The Paradox of Modern Anti-Obesity Drugs
As global demand for anti-obesity medications surges, a fierce pharmaceutical race is underway to develop next-generation successors to blockbusters...
Search results for "drugs"
Considering Wegovy for Weight Loss? South Korea's Drug Safety Ministry Warns It Is Not for Everyone
South Korea’s Ministry of Food and Drug Safety issued a strong warning on July 8 against the misuse and abuse of GLP-1 class anti-obesity...
"A Bike Is More Thrilling Than a Syringe Now": Inside South Korea's Last-Resort Hospital Treating 90% of Hospitalized Drug Addicts
A 190-centimeter-tall man with celebrity-grade looks opened the examination room door and walked in.
The GLP-1 Paradox: Wegovy and Mounjaro Patients Shed Weight, but Walk Less
"First I’ll lose the weight, and then I’ll start exercising."It is a thought shared by almost anyone starting highly...
New Blood Test Accurately Predicts Alzheimer’s Progression, Pinpointing Optimal Candidates for Treatment
Dementia medications do not yield uniform results for every patient; instead, their clinical efficacy depends heavily...
GLP-1 Weight-Loss Drugs: Potential Metabolic Instability Linked to Long-Term Use
A new study suggests that the long-term administration of GLP-1 receptor agonists—the class of anti-obesity medications...
Korean Researchers Uncover New Clues to Enhance Chronic Myeloid Leukemia Treatment
Korean researchers have uncovered a biological mechanism that could significantly improve the efficacy of treatments...
Osteoporosis Drugs That Can Be Hard to Keep Taking…Could ‘Sleeping Bone Cells’ Offer a Breakthrough?
Some patients need to rebuild bone quickly. These are people at high fracture risk—those who have already broken a bone...
Can 'Sound and Light' Treat the Brain? New Hope for Dementia Therapy Without Side Effects
A South Korean research team has demonstrated the potential for treating Alzheimer’s disease using non-invasive sound...
Resistance in the Genes: Why Popular Obesity Drugs Don’t Work for Everyone
GLP-1 receptor agonists like Wegovy and Mounjaro have fundamentally reshaped the treatment of diabetes and obesity.